Medspa and Dermatology Biologics Supplier in Duluth, MN

Physician Supervision and Vendor Review

Medspas are generally required to operate under the supervision of a licensed physician or medical director, and that medical director typically signs off on any new biologics supplier before it reaches the treatment room. Dermatology and plastic surgery practices generally route the same decision through the physician of record.

Precision Biologics supports that review with registration and licensure documentation, a donor eligibility summary, and certificate of analysis samples on request.

Account Verification by NPI

Because aesthetic practices range from solo dermatology offices to medspas with a supervising physician and several aestheticians, Precision Biologics ties each account to the NPI of the medical director or physician of record and confirms that number against the NPPES registry before activating the account.

Shipping and Storage for Aesthetic Practices

Cryopreserved Wharton's jelly products arrive overnight on dry ice in a validated container and are stored at -80 degrees Celsius; lyophilized exosome and Wharton's jelly formats are shelf-stable and are handled per the insert included with the lot. A practice without ultra-low freezer capacity on site may prefer a lyophilized format; Precision Biologics can walk through the storage requirements of each format during account setup.

Documentation and Medical Director Verification

Medical directors and practice owners can request the certificate of analysis, donor eligibility summary, and lot release record for a specific lot before approving it for use, and can arrange a documentation-focused call with Precision Biologics. Questions about medical-director requirements or scope of supervision in Minnesota should be directed to the Minnesota Board of Medical Practice and the practice's own counsel. These products are not FDA approved or licensed for any disease or condition; exosome products in particular have no FDA-approved equivalent on the market. Information here is for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.